Evidence map›Paper›PMID 30608705›Full record

ArticleMolecular pharmaceutics2019

3D Printing of Poloxamer 407 Nanogel Discs and Their Applications in Adjuvant Ovarian Cancer Therapy.

Hyunah Cho, Udayabhanu Jammalamadaka, Karthik Tappa, Christopher Egbulefu, Julie Prior, Rui Tang, Samuel Achilefu

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Nanotheranostics for gynecological cancers: a path forward for Africa.Medical oncology (Northwood, London, England) · 2024
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Nanocarrier-hydrogel composite delivery systems for precision drug release.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  20. 3D printing of pharmaceuticals for disease treatment.Frontiers in medical technology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hyunah ChoSchool of Pharmacy and Heath Sciences , Fairleigh Dickinson University , Florham Park , New Jersey 07932 , United States.ORCID 0000-0001-7150-4191
Udayabhanu JammalamadakaMallinckrodt Institute of Radiology , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Karthik TappaMallinckrodt Institute of Radiology , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Christopher EgbulefuMallinckrodt Institute of Radiology , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Julie PriorMallinckrodt Institute of Radiology , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Rui TangMallinckrodt Institute of Radiology , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Samuel AchilefuMallinckrodt Institute of Radiology , Washington University School of Medicine , St. Louis , Missouri 63110 , United States.
Mallinckrodt (United States) · USFairleigh Dickinson University · US

Funding

WU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI KOPAN, RAPHAEL · 2002 to 2016
$26.3M
Project 2 - Radiation-Induced Treatment of Multiple Myeloma using NanoparticlesU54CA199092 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2019
$11.5M
DEVELOPMENT OF GOGGLE SYSTEM FOR FLUORESCENCE IMAGE-GUIDED SURGERYR01CA171651 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2013 to 2017
$2.8M
IVIS Spectrum CT Preclinical In Vivo Imaging SystemS10OD027042 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2019 to 2019
$599k
FLUORESCENCE MOLECULAR TOMOGRAPHY SYSTEMS10OD020129 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2015 to 2015
$330k
FLUORESCENCE LIFETIME IMAGING MICROSCOPY SYSTEMS10OD016237 · OD · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2014 to 2014
$267k
NCI NIH HHS P50 CA094056NCI NIH HHS R01 CA171651NCI NIH HHS U54 CA199092NIH HHS S10 OD016237NIH HHS S10 OD020129NIH HHS S10 OD027042
6 · The paper itself

Abstract

Nanogels are attractive biocompatible materials that enable local delivery of multiple drugs. In this study, we demonstrated that 3D printing technology could be used to precisely construct nanogel discs carrying paclitaxel and rapamycin. 3D-printed nanogel disc rounds (12 mm diameter × 1 mm thickness) carrying paclitaxel and rapamycin evaded premature gelation during storage and the initial burst release of the drugs in the dissolution medium. In vivo 3D-printed nanogel discs permitted successful intraperitoneal delivery of paclitaxel and rapamycin in ES-2-luc ovarian-cancer-bearing xenograft mice. They were also shown to be therapeutically effective and capable of preventing postsurgical peritoneal adhesions in the treated xenograft mice.

Indexed as

Printing, Three-DimensionalAnimalsAntibiotics, AntineoplasticFemaleHumansMiceOvarian NeoplasmsPaclitaxelPoloxamerSirolimusXenograft Model Antitumor AssaysAntibiotics, AntineoplasticPaclitaxelPoloxamerSirolimus3D printingovarian cancerpaclitaxelperitoneal adhesionpoloxamer

Identifiers

PMID30608705
PMCPMC7357236
OpenAlexW2908466941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.